APO Research
Talk to an analyst

APO RESEARCH · REPORT

Binge Eating Disorder Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Binge Eating Disorder Drug Industry Growth and Trends Forecast to 2032

20 December 202595 pages

Choose your research edition.

Industry ResearchBinge Eating Disorder Drug Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Binge Eating Disorder Drug Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Binge Eating Disorder Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Binge Eating Disorder Drug Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Binge Eating Disorder Drug Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Binge Eating Disorder Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Binge Eating Disorder Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Binge Eating Disorder Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Binge Eating Disorder Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Binge Eating Disorder Drug include Novo Nordisk, Roche, Sunovion Pharmaceuticals, Opiant Pharmaceuticals, Omeros Corp, Heptares and Chronos Therapeutics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Binge Eating Disorder Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Binge Eating Disorder Drug market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Binge Eating Disorder Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Binge Eating Disorder Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Binge Eating Disorder Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Binge Eating Disorder Drug Market by Company

Novo Nordisk

Roche

Sunovion Pharmaceuticals

Opiant Pharmaceuticals

Omeros Corp

Heptares

Chronos Therapeutics

Binge Eating Disorder Drug Segment by Type

Anti-obesity Medications

Anticonvulsants

Antidepressants

Binge Eating Disorder Drug Segment by Application

Retail Pharmacies

Online Pharmacies

Hospital Pharmacies

Binge Eating Disorder Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Binge Eating Disorder Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Binge Eating Disorder Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Binge Eating Disorder Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Binge Eating Disorder Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Binge Eating Disorder Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Anti-obesity Medications Table 2. Major Company of Anticonvulsants Table 3. Major Company of Antidepressants Table 4. Global Binge Eating Disorder Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Binge Eating Disorder Drug Sales by Type (2021-2026) & (K Units) Table 6. Global Binge Eating Disorder Drug Sales Market Share in Volume by Type (2021-2026) Table 7. Global Binge Eating Disorder Drug Sales by Type (2021-2026) & (US$ Million) Table 8. Global Binge Eating Disorder Drug Sales Market Share in Value by Type (2021-2026) Table 9. Global Binge Eating Disorder Drug Price by Type (2021-2026) & (US$/Unit) Table 10. Global Binge Eating Disorder Drug Sales by Type (2027-2032) & (K Units) Table 11. Global Binge Eating Disorder Drug Sales Market Share in Volume by Type (2027-2032) Table 12. Global Binge Eating Disorder Drug Sales by Type (2027-2032) & (US$ Million) Table 13. Global Binge Eating Disorder Drug Sales Market Share in Value by Type (2027-2032) Table 14. Global Binge Eating Disorder Drug Price by Type (2027-2032) & (US$/Unit) Table 15. North America Binge Eating Disorder Drug Sales by Type (2021-2026) & (K Units) Table 16. North America Binge Eating Disorder Drug Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Binge Eating Disorder Drug Sales by Type (2021-2026) & (K Units) Table 18. Europe Binge Eating Disorder Drug Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Binge Eating Disorder Drug Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Binge Eating Disorder Drug Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Binge Eating Disorder Drug Sales by Type (2021-2026) & (K Units) Table 22. Latin America Binge Eating Disorder Drug Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Binge Eating Disorder Drug Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Binge Eating Disorder Drug Sales by Type (2021-2026) & (US$ Million) Table 25. Binge Eating Disorder Drug Industry Trends Table 26. Binge Eating Disorder Drug Industry Drivers Table 27. Binge Eating Disorder Drug Industry Opportunities and Challenges Table 28. Binge Eating Disorder Drug Industry Restraints Table 29. Global Binge Eating Disorder Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Binge Eating Disorder Drug Revenue Market Share by Company (2021-2026) Table 31. Global Binge Eating Disorder Drug Sales by Company (2021-2026) & (K Units) Table 32. Global Binge Eating Disorder Drug Sales Share by Company (2021-2026) Table 33. Global Binge Eating Disorder Drug Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Binge Eating Disorder Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Binge Eating Disorder Drug Major Company Production Sites and Headquarters Table 36. Global Binge Eating Disorder Drug Company, Product Type & Application Table 37. Global Binge Eating Disorder Drug Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Binge Eating Disorder Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Binge Eating Disorder Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Binge Eating Disorder Drug Sales by Region (2021-2026) & (K Units) Table 42. Global Binge Eating Disorder Drug Sales Market Share in Volume by Region (2021-2026) Table 43. Global Binge Eating Disorder Drug Sales by Region (2021-2026) & (US$ Million) Table 44. Global Binge Eating Disorder Drug Sales Market Share in Value by Region (2021-2026) Table 45. Global Binge Eating Disorder Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Binge Eating Disorder Drug Sales by Region (2027-2032) & (K Units) Table 47. Global Binge Eating Disorder Drug Sales Market Share in Volume by Region (2027-2032) Table 48. Global Binge Eating Disorder Drug Sales by Region (2027-2032) & (US$ Million) Table 49. Global Binge Eating Disorder Drug Sales Market Share in Value by Region (2027-2032) Table 50. Global Binge Eating Disorder Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Binge Eating Disorder Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Binge Eating Disorder Drug Sales by Application (2021-2026) & (K Units) Table 53. Global Binge Eating Disorder Drug Sales Market Share in Volume by Application (2021-2026) Table 54. Global Binge Eating Disorder Drug Sales by Application (2021-2026) & (US$ Million) Table 55. Global Binge Eating Disorder Drug Sales Market Share in Value by Application (2021-2026) Table 56. Global Binge Eating Disorder Drug Price by Application (2021-2026) & (US$/Unit) Table 57. Global Binge Eating Disorder Drug Sales by Application (2027-2032) & (K Units) Table 58. Global Binge Eating Disorder Drug Sales Market Share in Volume by Application (2027-2032) Table 59. Global Binge Eating Disorder Drug Sales by Application (2027-2032) & (US$ Million) Table 60. Global Binge Eating Disorder Drug Sales Market Share in Value by Application (2027-2032) Table 61. Global Binge Eating Disorder Drug Price by Application (2027-2032) & (US$/Unit) Table 62. North America Binge Eating Disorder Drug Sales by Application (2021-2026) & (K Units) Table 63. North America Binge Eating Disorder Drug Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Binge Eating Disorder Drug Sales by Application (2021-2026) & (K Units) Table 65. Europe Binge Eating Disorder Drug Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Binge Eating Disorder Drug Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Binge Eating Disorder Drug Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Binge Eating Disorder Drug Sales by Application (2021-2026) & (K Units) Table 69. Latin America Binge Eating Disorder Drug Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Binge Eating Disorder Drug Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Binge Eating Disorder Drug Sales by Application (2021-2026) & (US$ Million) Table 72. Novo Nordisk Company Information Table 73. Novo Nordisk Business Overview Table 74. Novo Nordisk Binge Eating Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Novo Nordisk Binge Eating Disorder Drug Product Portfolio Table 76. Novo Nordisk Recent Development Table 77. Roche Company Information Table 78. Roche Business Overview Table 79. Roche Binge Eating Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Roche Binge Eating Disorder Drug Product Portfolio Table 81. Roche Recent Development Table 82. Sunovion Pharmaceuticals Company Information Table 83. Sunovion Pharmaceuticals Business Overview Table 84. Sunovion Pharmaceuticals Binge Eating Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Sunovion Pharmaceuticals Binge Eating Disorder Drug Product Portfolio Table 86. Sunovion Pharmaceuticals Recent Development Table 87. Opiant Pharmaceuticals Company Information Table 88. Opiant Pharmaceuticals Business Overview Table 89. Opiant Pharmaceuticals Binge Eating Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Opiant Pharmaceuticals Binge Eating Disorder Drug Product Portfolio Table 91. Opiant Pharmaceuticals Recent Development Table 92. Omeros Corp Company Information Table 93. Omeros Corp Business Overview Table 94. Omeros Corp Binge Eating Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Omeros Corp Binge Eating Disorder Drug Product Portfolio Table 96. Omeros Corp Recent Development Table 97. Heptares Company Information Table 98. Heptares Business Overview Table 99. Heptares Binge Eating Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Heptares Binge Eating Disorder Drug Product Portfolio Table 101. Heptares Recent Development Table 102. Chronos Therapeutics Company Information Table 103. Chronos Therapeutics Business Overview Table 104. Chronos Therapeutics Binge Eating Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Chronos Therapeutics Binge Eating Disorder Drug Product Portfolio Table 106. Chronos Therapeutics Recent Development Table 107. North America Binge Eating Disorder Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 108. North America Binge Eating Disorder Drug Sales by Country (2021-2026) & (K Units) Table 109. North America Binge Eating Disorder Drug Sales Market Share by Country (2021-2026) Table 110. North America Binge Eating Disorder Drug Sales Forecast by Country (2027-2032) & (K Units) Table 111. North America Binge Eating Disorder Drug Sales Market Share Forecast by Country (2027-2032) Table 112. North America Binge Eating Disorder Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 113. North America Binge Eating Disorder Drug Market Size by Country (2021-2026) & (US$ Million) Table 114. North America Binge Eating Disorder Drug Market Share by Country (2021-2026) Table 115. North America Binge Eating Disorder Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 116. North America Binge Eating Disorder Drug Market Share Forecast by Country (2027-2032) Table 117. Europe Binge Eating Disorder Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 118. Europe Binge Eating Disorder Drug Sales by Country (2021-2026) & (K Units) Table 119. Europe Binge Eating Disorder Drug Sales Market Share by Country (2021-2026) Table 120. Europe Binge Eating Disorder Drug Sales Forecast by Country (2027-2032) & (K Units) Table 121. Europe Binge Eating Disorder Drug Sales Market Share Forecast by Country (2027-2032) Table 122. Europe Binge Eating Disorder Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 123. Europe Binge Eating Disorder Drug Market Size by Country (2021-2026) & (US$ Million) Table 124. Europe Binge Eating Disorder Drug Market Share by Country (2021-2026) Table 125. Europe Binge Eating Disorder Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 126. Europe Binge Eating Disorder Drug Market Share Forecast by Country (2027-2032) Table 127. Asia-Pacific Binge Eating Disorder Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 128. Asia-Pacific Binge Eating Disorder Drug Sales by Country (2021-2026) & (K Units) Table 129. Asia-Pacific Binge Eating Disorder Drug Sales Market Share by Country (2021-2026) Table 130. Asia-Pacific Binge Eating Disorder Drug Sales Forecast by Country (2027-2032) & (K Units) Table 131. Asia-Pacific Binge Eating Disorder Drug Sales Market Share Forecast by Country (2027-2032) Table 132. Asia-Pacific Binge Eating Disorder Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. Asia-Pacific Binge Eating Disorder Drug Market Size by Country (2021-2026) & (US$ Million) Table 134. Asia-Pacific Binge Eating Disorder Drug Market Share by Country (2021-2026) Table 135. Asia-Pacific Binge Eating Disorder Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. Asia-Pacific Binge Eating Disorder Drug Market Share Forecast by Country (2027-2032) Table 137. Latin America Binge Eating Disorder Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 138. Latin America Binge Eating Disorder Drug Sales by Country (2021-2026) & (K Units) Table 139. Latin America Binge Eating Disorder Drug Sales Market Share by Country (2021-2026) Table 140. Latin America Binge Eating Disorder Drug Sales Forecast by Country (2027-2032) & (K Units) Table 141. Latin America Binge Eating Disorder Drug Sales Market Share Forecast by Country (2027-2032) Table 142. Latin America Binge Eating Disorder Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Latin America Binge Eating Disorder Drug Market Size by Country (2021-2026) & (US$ Million) Table 144. Latin America Binge Eating Disorder Drug Market Share by Country (2021-2026) Table 145. Latin America Binge Eating Disorder Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Latin America Binge Eating Disorder Drug Market Share Forecast by Country (2027-2032) Table 147. Middle East and Africa Binge Eating Disorder Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 148. Middle East and Africa Binge Eating Disorder Drug Sales by Country (2021-2026) & (K Units) Table 149. Middle East and Africa Binge Eating Disorder Drug Sales Market Share by Country (2021-2026) Table 150. Middle East and Africa Binge Eating Disorder Drug Sales Forecast by Country (2027-2032) & (K Units) Table 151. Middle East and Africa Binge Eating Disorder Drug Sales Market Share Forecast by Country (2027-2032) Table 152. Middle East and Africa Binge Eating Disorder Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Middle East and Africa Binge Eating Disorder Drug Market Size by Country (2021-2026) & (US$ Million) Table 154. Middle East and Africa Binge Eating Disorder Drug Market Share by Country (2021-2026) Table 155. Middle East and Africa Binge Eating Disorder Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Middle East and Africa Binge Eating Disorder Drug Market Share Forecast by Country (2027-2032) Table 157. Key Raw Materials Table 158. Raw Materials Key Suppliers Table 159. Binge Eating Disorder Drug Distributors List Table 160. Binge Eating Disorder Drug Customers List Table 161. Research Programs/Design for This Report Table 162. Authors List of This Report Table 163. Secondary Sources Table 164. Primary Sources List of Figures Figure 1. Binge Eating Disorder Drug Image Figure 2. Global Binge Eating Disorder Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Binge Eating Disorder Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Binge Eating Disorder Drug Sales (2021-2032) & (K Units) Figure 5. Anti-obesity Medications Image Figure 6. Global Anti-obesity Medications Sales YoY Growth (2021-2032) & (K Units) Figure 7. Anticonvulsants Image Figure 8. Global Anticonvulsants Sales YoY Growth (2021-2032) & (K Units) Figure 9. Antidepressants Image Figure 10. Global Antidepressants Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Binge Eating Disorder Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Binge Eating Disorder Drug Market Share by Type 2025 VS 2032 Figure 13. North America Binge Eating Disorder Drug Sales Market Share in Volume by Type in 2025 Figure 14. North America Binge Eating Disorder Drug Sales Market Share in Value by Type in 2025 Figure 15. Europe Binge Eating Disorder Drug Sales Market Share in Volume by Type in 2025 Figure 16. Europe Binge Eating Disorder Drug Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Binge Eating Disorder Drug Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Binge Eating Disorder Drug Sales Market Share in Value by Type in 2025 Figure 19. Latin America Binge Eating Disorder Drug Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Binge Eating Disorder Drug Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Binge Eating Disorder Drug Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Binge Eating Disorder Drug Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Binge Eating Disorder Drug Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Retail Pharmacies Image Figure 26. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 27. Online Pharmacies Image Figure 28. Global Online Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 29. Hospital Pharmacies Image Figure 30. Global Hospital Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Binge Eating Disorder Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Binge Eating Disorder Drug Market Share by Application 2025 VS 2032 Figure 33. North America Binge Eating Disorder Drug Sales Market Share in Volume by Application in 2025 Figure 34. North America Binge Eating Disorder Drug Sales Market Share in Value by Application in 2025 Figure 35. Europe Binge Eating Disorder Drug Sales Market Share in Volume by Application in 2025 Figure 36. Europe Binge Eating Disorder Drug Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Binge Eating Disorder Drug Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Binge Eating Disorder Drug Sales Market Share in Value by Application in 2025 Figure 39. Latin America Binge Eating Disorder Drug Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Binge Eating Disorder Drug Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Binge Eating Disorder Drug Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Binge Eating Disorder Drug Sales Market Share in Value by Application in 2025 Figure 43. North America Binge Eating Disorder Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Binge Eating Disorder Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Binge Eating Disorder Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Binge Eating Disorder Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Binge Eating Disorder Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Binge Eating Disorder Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Binge Eating Disorder Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Binge Eating Disorder Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Binge Eating Disorder Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Binge Eating Disorder Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Binge Eating Disorder Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Binge Eating Disorder Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Binge Eating Disorder Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Binge Eating Disorder Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Binge Eating Disorder Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Binge Eating Disorder Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Binge Eating Disorder Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Binge Eating Disorder Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Binge Eating Disorder Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Binge Eating Disorder Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Binge Eating Disorder Drug Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Binge Eating Disorder Drug Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Anti-obesity Medications
  • Anticonvulsants
  • Antidepressants
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
Companies covered
  • Novo Nordisk
  • Roche
  • Sunovion Pharmaceuticals
  • Opiant Pharmaceuticals
  • Omeros Corp
  • Heptares
  • Chronos Therapeutics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Binge Eating Disorder Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Binge Eating Disorder Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Binge Eating Disorder Drug Market by Type
  6. 1.3.1 Anti-obesity Medications
  7. 1.3.2 Anticonvulsants
  8. 1.3.3 Antidepressants
  9. 1.4 Global Binge Eating Disorder Drug Market Size by Type
  10. 1.4.1 Global Binge Eating Disorder Drug Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Binge Eating Disorder Drug Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Binge Eating Disorder Drug Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Binge Eating Disorder Drug Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Binge Eating Disorder Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Binge Eating Disorder Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Binge Eating Disorder Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Binge Eating Disorder Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Binge Eating Disorder Drug Industry Trends
  2. 2.2 Binge Eating Disorder Drug Industry Drivers
  3. 2.3 Binge Eating Disorder Drug Industry Opportunities and Challenges
  4. 2.4 Binge Eating Disorder Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Binge Eating Disorder Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Binge Eating Disorder Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Binge Eating Disorder Drug Price (2021-2026)
  4. 3.4 Global Binge Eating Disorder Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Binge Eating Disorder Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Binge Eating Disorder Drug Company, Product Type & Application
  7. 3.7 Global Binge Eating Disorder Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Binge Eating Disorder Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Binge Eating Disorder Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Binge Eating Disorder Drug Tier 1, Tier 2, and Tier 3
4 Binge Eating Disorder Drug Regional Status and Outlook
  1. 4.1 Global Binge Eating Disorder Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Binge Eating Disorder Drug Historic Market Size by Region
  3. 4.2.1 Global Binge Eating Disorder Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Binge Eating Disorder Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Binge Eating Disorder Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Binge Eating Disorder Drug Forecasted Market Size by Region
  7. 4.3.1 Global Binge Eating Disorder Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Binge Eating Disorder Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Binge Eating Disorder Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Binge Eating Disorder Drug by Application
  1. 5.1 Binge Eating Disorder Drug Market by Application
  2. 5.1.1 Retail Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Hospital Pharmacies
  5. 5.2 Global Binge Eating Disorder Drug Market Size by Application
  6. 5.2.1 Global Binge Eating Disorder Drug Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Binge Eating Disorder Drug Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Binge Eating Disorder Drug Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Binge Eating Disorder Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Binge Eating Disorder Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Binge Eating Disorder Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Binge Eating Disorder Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Binge Eating Disorder Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Novo Nordisk
  2. 6.1.1 Novo Nordisk Company Information
  3. 6.1.2 Novo Nordisk Business Overview
  4. 6.1.3 Novo Nordisk Binge Eating Disorder Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Novo Nordisk Binge Eating Disorder Drug Product Portfolio
  6. 6.1.5 Novo Nordisk Recent Developments
  7. 6.2 Roche
  8. 6.2.1 Roche Company Information
  9. 6.2.2 Roche Business Overview
  10. 6.2.3 Roche Binge Eating Disorder Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Roche Binge Eating Disorder Drug Product Portfolio
  12. 6.2.5 Roche Recent Developments
  13. 6.3 Sunovion Pharmaceuticals
  14. 6.3.1 Sunovion Pharmaceuticals Company Information
  15. 6.3.2 Sunovion Pharmaceuticals Business Overview
  16. 6.3.3 Sunovion Pharmaceuticals Binge Eating Disorder Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sunovion Pharmaceuticals Binge Eating Disorder Drug Product Portfolio
  18. 6.3.5 Sunovion Pharmaceuticals Recent Developments
  19. 6.4 Opiant Pharmaceuticals
  20. 6.4.1 Opiant Pharmaceuticals Company Information
  21. 6.4.2 Opiant Pharmaceuticals Business Overview
  22. 6.4.3 Opiant Pharmaceuticals Binge Eating Disorder Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Opiant Pharmaceuticals Binge Eating Disorder Drug Product Portfolio
  24. 6.4.5 Opiant Pharmaceuticals Recent Developments
  25. 6.5 Omeros Corp
  26. 6.5.1 Omeros Corp Company Information
  27. 6.5.2 Omeros Corp Business Overview
  28. 6.5.3 Omeros Corp Binge Eating Disorder Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Omeros Corp Binge Eating Disorder Drug Product Portfolio
  30. 6.5.5 Omeros Corp Recent Developments
  31. 6.6 Heptares
  32. 6.6.1 Heptares Company Information
  33. 6.6.2 Heptares Business Overview
  34. 6.6.3 Heptares Binge Eating Disorder Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Heptares Binge Eating Disorder Drug Product Portfolio
  36. 6.6.5 Heptares Recent Developments
  37. 6.7 Chronos Therapeutics
  38. 6.7.1 Chronos Therapeutics Company Information
  39. 6.7.2 Chronos Therapeutics Business Overview
  40. 6.7.3 Chronos Therapeutics Binge Eating Disorder Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Chronos Therapeutics Binge Eating Disorder Drug Product Portfolio
  42. 6.7.5 Chronos Therapeutics Recent Developments
7 North America by Country
  1. 7.1 North America Binge Eating Disorder Drug Sales by Country
  2. 7.1.1 North America Binge Eating Disorder Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Binge Eating Disorder Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Binge Eating Disorder Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Binge Eating Disorder Drug Market Size by Country
  6. 7.2.1 North America Binge Eating Disorder Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Binge Eating Disorder Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Binge Eating Disorder Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Binge Eating Disorder Drug Sales by Country
  2. 8.1.1 Europe Binge Eating Disorder Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Binge Eating Disorder Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Binge Eating Disorder Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Binge Eating Disorder Drug Market Size by Country
  6. 8.2.1 Europe Binge Eating Disorder Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Binge Eating Disorder Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Binge Eating Disorder Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Binge Eating Disorder Drug Sales by Country
  2. 9.1.1 Asia-Pacific Binge Eating Disorder Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Binge Eating Disorder Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Binge Eating Disorder Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Binge Eating Disorder Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Binge Eating Disorder Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Binge Eating Disorder Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Binge Eating Disorder Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Binge Eating Disorder Drug Sales by Country
  2. 10.1.1 South America Binge Eating Disorder Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Binge Eating Disorder Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Binge Eating Disorder Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Binge Eating Disorder Drug Market Size by Country
  6. 10.2.1 South America Binge Eating Disorder Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Binge Eating Disorder Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Binge Eating Disorder Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Binge Eating Disorder Drug Sales by Country
  2. 11.1.1 Middle East and Africa Binge Eating Disorder Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Binge Eating Disorder Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Binge Eating Disorder Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Binge Eating Disorder Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Binge Eating Disorder Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Binge Eating Disorder Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Binge Eating Disorder Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Binge Eating Disorder Drug Value Chain Analysis
  2. 12.1.1 Binge Eating Disorder Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Binge Eating Disorder Drug Production Mode & Process
  7. 12.2 Binge Eating Disorder Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Binge Eating Disorder Drug Distributors
  10. 12.2.3 Binge Eating Disorder Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst